Lucía Barbier-Torres Selected Research

Fatty Acids (Saturated Fatty Acids)

1/2020	Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation.
11/2019	miR-873-5p targets mitochondrial GNMT-Complex II interface contributing to non-alcoholic fatty liver disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lucía Barbier-Torres Research Topics

Disease

7	Non-alcoholic Fatty Liver Disease 02/2023 - 02/2016
4	Mitochondrial Diseases (Mitochondrial Disease) 01/2024 - 12/2017
4	Liver Diseases (Liver Disease) 01/2024 - 01/2017
4	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023 - 10/2015
4	Neoplasms (Cancer) 01/2021 - 02/2015
4	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 05/2014
4	Fibrosis (Cirrhosis) 01/2020 - 01/2017
3	Cholestasis 06/2021 - 10/2015
3	Fatty Liver 11/2019 - 02/2016
3	Inflammation (Inflammations) 11/2019 - 01/2017
2	Carcinogenesis 07/2023 - 05/2014
2	Alcoholic Fatty Liver 01/2020 - 01/2020
1	Cholangiocarcinoma 07/2023
1	Hyperplasia 07/2023
1	Anemia 01/2023
1	Liver Neoplasms (Liver Cancer) 01/2022
1	Hypoxia (Hypoxemia) 02/2019
1	Fever (Fevers) 12/2017
1	Pain (Aches) 12/2017
1	Hyperammonemia 01/2017
1	Hypermethioninemia 02/2016
1	Chemical and Drug Induced Liver Injury 01/2015

Drug/Important Bio-Agent (IBA)

5	S-Adenosylmethionine (Ademetionine)IBA 01/2024 - 02/2016
4	LipidsIBA 01/2024 - 02/2016
3	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2020
3	MyokinesIBA 01/2023 - 01/2022
3	AdipokinesIBA 01/2023 - 01/2022
3	Phosphotransferases (Kinase)IBA 01/2022 - 02/2019
3	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2018
2	CytokinesIBA 01/2022 - 01/2022
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2020 - 11/2019
2	Glycine N-Methyltransferase (Glycine Sarcosine N-Methyltransferase)IBA 11/2019 - 02/2016
2	UbiquitinIBA 02/2019 - 01/2017
2	pevonedistatIBA 01/2017 - 02/2015
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 07/2023
1	Interleukin-6 (Interleukin 6)IBA 07/2023
1	HMGB1 Protein (HMG1)IBA 07/2023
1	Casein Kinase II (Casein Kinase 2)IBA 07/2023
1	silmitasertibIBA 07/2023
1	ProteomeIBA 02/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2023
1	Methionine AdenosyltransferaseIBA 01/2022
1	IsomerasesIBA 01/2022
1	SilymarinIBA 01/2022
1	ribosomal protein S3IBA 01/2022
1	ribosomal protein L18IBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2021
1	Bile Acids and Salts (Bile Acids)IBA 06/2021
1	Sorafenib (BAY 43-9006)FDA Link 01/2021
1	GlutaminaseIBA 01/2020
1	very low density lipoprotein triglycerideIBA 01/2020
1	ProhibitinsIBA 01/2020
1	Small Interfering RNA (siRNA)IBA 01/2020
1	EnzymesIBA 11/2019
1	myristoylmethionine (M-L-M)IBA 02/2019
1	Histidine (L-Histidine)FDA Link 02/2019
1	Acetaminophen (Paracetamol)FDA LinkGeneric 12/2017
1	AmmoniaIBA 01/2017
1	Methionine (L-Methionine)FDA Link 02/2016
1	parthenolideIBA 10/2015
1	Histone Deacetylase InhibitorsIBA 10/2015
1	Phosphatidylcholines (Phosphatidylcholine)IBA 02/2015
1	Biomarkers (Surrogate Marker)IBA 01/2015
1	Sirtuin 1IBA 05/2014

Therapy/Procedure

3	Ligation 06/2021 - 10/2015
1	Therapeutics 11/2019